drugset / Trial / NCT01572688

Safety and Efficacy Study of High Dose Melphalan to Treat Multiple Myeloma

NCT01572688

NaSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to evaluate the safety and effectiveness of melphalan for injection for autologous stem cell transplant in multiple myeloma

Timeline

Start
2011-11
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Melphalan Small molecule 200 mg/m2

Indications